Tirzepatide and the risk of atherosclerotic cardiovascular events: population based cohort study.

문헌 요약

To estimate the magnitude of reduction in major adverse cardiovascular events (MACE) that would be observed in clinical practice from adding tirzepatide to standard of care treatment. Population based cohort study, using a design, data, and analytical approach previously benchmarked against randomised trials. Two national US claims databases, May 2022 to…